The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Opposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS
Open accessAbstract
T cell-mediated fulminant hepatitis is a life-threatening event for which the underlying mechanism is not fully understood. Injection of concanavalin A (Con A) into mice recapitulates the histological and pathological sequelae of T cell-mediated hepatitis. In this model, both signal transducer and activator of transcription factor 1 (STAT1) and STAT3 are activated in the liver. Disruption of the STAT1 gene by way of genetic knockout attenuates liver injury, suppresses CD4(+) and NK T cell activation, and downregulates expression of proapoptotic interferon regulatory factor-1 protein and suppressor of cytokine signaling-1 (SOCS1), but enhances STAT3 activation and STAT3-controlled antiapoptotic signals. Studies from IFN-gamma-deficient mice indicate that IFN-gamma not only is the major cytokine responsible for STAT1 activation but also partially accounts for STAT3 activation. Moreover, downregulation of STAT3 activation in IL-6-deficient mice is associated with decreased STAT3-controlled antiapoptotic signals and expression of SOCS3, but upregulation of STAT1 activation and STAT1-induced proapoptotic signals and exacerbation of liver injury. Taken together, these findings suggest that STAT1 plays a harmful role in Con A-mediated hepatitis by activation of CD4(+) and NK T cells and directly inducing hepatocyte death, whereas STAT3 protects against liver injury by suppression of IFN-gamma signaling and induction of antiapoptotic protein Bcl-X(L). STAT1 and STAT3 in hepatocytes also negatively regulate one another through the induction of SOCS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538 · cited 2×
“IL-6 is the major cytokine responsible for STAT3 activation in liver regeneration (25) and CCl4-induced liver injury (26), since such activation is not detectable in IL-6–/– mice under these conditions.”
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
A T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs, G., Hentschel, J., & Wendel, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115836 · Cited by 1,074
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80047-1 · Cited by 762
Critical contribution of liver natural killer T cells to a murine model of hepatitis
Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H., & Okumura, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040566697 · Cited by 539
Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517
Kusters, S., Gantner, F., Kunstle, G., & Tiegs, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690213 · Cited by 432
Kamiya, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2127 · Cited by 427
Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M., & McCaughan, G. W. (1996) · Hepatology · doi:10.1002/hep.510240402 · Cited by 412
Nicholson, S. E., Willson, T. A., Farley, A., Starr, R., Zhang, J., Baca, M., Alexander, W. S., Metcalf, D., Hilton, D. J., & Nicola, N. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.375 · Cited by 407
Tagawa, Y., Sekikawa, K., & Iwakura, Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1418 · Cited by 401
Cytokines in Alcoholic Liver Disease
McClain, C., Barve, S., Deaciuc, I., Kugelmas, M., & Hill, D. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007110 · Cited by 399
Kaneko, Y., Harada, M., Kawano, T., Yamashita, M., Shibata, Y., Gejyo, F., Nakayama, T., & Taniguchi, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.105 · Cited by 396
Cytotoxic T cells and viral hepatitis.
Chisari, F. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119308 · Cited by 367
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
Chang, K.-M., Thimme, R., Melpolder, J. J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J. G., Alter, H. J., & Chisari, F. V. (2001) · Hepatology · doi:10.1053/jhep.2001.21162 · Cited by 336
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000) · Hepatology · doi:10.1002/hep.510310123 · Cited by 298
Kovalovich, K., Li, W., DeAngelis, R., Greenbaum, L. E., Ciliberto, G., & Taub, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100740200 · Cited by 280
A Sequential Two-Step Mechanism for the Production of the Mature p17:p12 Form of Caspase-3 in Vitro
Han, Z., Hendrickson, E. A., Bremner, T. A., & Wyche, J. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13432 · Cited by 243
Regulation of Bcl-xL: a little bit of this and a little bit of STAT
Grad, J. M., Zeng, X.-R., & Boise, L. H. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00006 · Cited by 231
Koziel, M. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007107 · Cited by 216
Role of Jak Kinases and STATs in Cytokine Signal Transduction
Leonard, W. J. (2001) · International Journal of Hematology · doi:10.1007/bf02981951 · Cited by 215
Current and novel immunosuppressive therapy for autoimmune hepatitis
Heneghan, M. A., & McFarlane, I. G. (2002) · Hepatology · doi:10.1053/jhep.2002.30991 · Cited by 210
Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita, Y., Nakagawa, Narazaki, M., Adachi, K., Yoshimoto, T., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00132-7 · Cited by 186
Hong, F., Kim, W.-H., Tian, Z., Jaruga, B., Ishac, E., Shen, X., & Gao, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205016 · Cited by 179 · cited 2×
“Additionally, induction of the antiapoptotic Bcl-XL protein expression in hepatocytes may be another mechanism contributing to IL-6/STAT3-mediated protection against Con A– induced liver injury because Bcl-XL, which is elevated and positively regulated by IL-6/STAT3 in Con A– induced hepatitis (Figure 2d and Figure 5a…”
Self-citationRosen, H. R., Miner, C., Sasaki, A. W., Lewinsohn, D. M., Conrad, A. J., Bakke, A., Bouwer, A. H. G., & Hinrichs, D. J. (2002) · Hepatology · doi:10.1053/jhep.2002.30293 · Cited by 168
SOCS proteins, regulators of intracellular signaling.
Chen, X.-P., Losman, J., & Rothman, P. (2000) · Immunity · doi:10.1016/s1074-7613(00)00028-5 · Cited by 162
The lymphoid liver: Considerations on pathways to autoimmune injury
Kita, H., Van De Water, J., Gershwin, M. E., & Mackay, I. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.22441 · Cited by 158
Expression of suppressors of cytokine signaling during liver regeneration
Campbell, J. S., Prichard, L., Schaper, F., Schmitz, J., Stephenson-Famy, A., Rosenfeld, M. E., Argast, G. M., Heinrich, P. C., & Fausto, N. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11867 · Cited by 156 · cited 2×
“In this model, SOCS3 but not SOCS1 is markedly induced, which correlates with activation of STAT3 but absent STAT1 activation (52).”
Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., Tannahill, C. L., Solórzano, C. C., Norman, J., Denham, W., Clare-Salzler, M. J., MacKay, S. L., et al. (1998) · PubMed · Cited by 156
Cytokines and JAK–STAT Signaling
Schindler, C. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4670 · Cited by 148
Kano, A., Haruyama, T., Akaike, T., & Watanabe, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0276 · Cited by 137
Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis
Martinez, O. M., Villanueva, J. C., Gershwin, E. M., & Krams, S. M. (1995) · Hepatology · doi:10.1002/hep.1840210120 · Cited by 134
Cell Mediated Immune Response to the Hepatitis C Virus
Rehermann, B., & Chisari, F. V. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_14 · Cited by 127
Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes
Radaeva, S., Jaruga, B., Hong, F., Kim, W., Fan, S., Cai, H., Strom, S. C., Liu, Y., El-Assal, O. N., & Gao, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.32388 · Cited by 127
Self-citationNegative regulation of cytokine signaling: STAT-induced STAT inhibitor.
Naka, T., Fujimoto, M., & Kishimoto, T. (1999) · TIBS -Trends in Biochemical Sciences. Regular ed · doi:10.1016/s0968-0004(99)01454-1 · Cited by 126
Cell-mediated hepatic injury in alcoholic liver disease
Chedid, A., Mendenhall, C. L., Moritz, T. E., French, S. W., Chen, T., Morgan, T. R. M., Roselle, G. A., Nemchausky, B. A., Tamburro, C. H., Schiff, E. R., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90034-a · Cited by 117
Wolf, D., Hallmann, R., Sass, G., Sixt, M., Küsters, S., Fregien, B., Trautwein, C., & Tiegs, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1300 · Cited by 109
Fiorucci, S., Santucci, L., Antonelli, E., Distrutti, E., Sero, G. D., Morelli, O., Romani, L. R., Federici, B., Soldato, P. D., & Morelli, A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70223-x · Cited by 108
Künstle, G., Hentze, H., Germann, P., Tiegs, G., Meergans, T., & Wendel, A. (1999) · Hepatology · doi:10.1002/hep.510300517 · Cited by 104
Löhr, H. F., Schlaak, J., Lohse, A. W., Böcher, W. O., Arenz, M., Gerken, G., & Büschenfelde, K. M. Z. (1996) · Hepatology · doi:10.1002/hep.510240619 · Cited by 99
Chen, D., McKallip, R. J., Zeytun, A., Do, Y., Lombard, C. A., Robertson, J. L., Mak, T. W., Nagarkatti, P. S., & Nagarkatti, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5889 · Cited by 97
Saito, H., Morita, Y., Fujimoto, M., Narazaki, M., Naka, T., & Kishimoto, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5833 · Cited by 97
Tagawa, Y., Kakuta, S., & Iwakura, Y. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12<4105::aid-immu4105>3.0.co;2-8 · Cited by 96
Huang, Y.-Q., Li, J., & Karpatkin, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6462 · Cited by 90
Bogdanos, D. P., Mieli‐Vergani, G., & Vergani, D. (2000) · Digestive and Liver Disease · doi:10.1016/s1590-8658(00)80266-2 · Cited by 82
Differential protective effects of Bcl-xLand Bcl-2 on apoptotic liver injury in transgenic mice
Coste, A. D. L., Fabrè, M., McDonell, N., Porteu, A., Gilgenkrantz, H., Perret, C., Kahn, A., & Mignon, A. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.3.g702 · Cited by 71
Cytokine profile of viral and autoimmune chronic active hepatitis
Al-Wabel, A., Al‐Janadi, M., & Raziuddin, S. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90068-q · Cited by 48
Negative Regulation of Cytokine Signaling by the SOCS ProteinsPreprint
Nicola, N. A., Nicholson, S. E., Metcalf, D., Zhang, J., Baca, M., Farley, A., Willson, T. A., Starr, R., Alexander, W. S., & Hilton, D. J. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.397 · Cited by 33
A Broad-Spectrum Caspase Inhibitor Blocks Concanavalin A-Induced Hepatitis in Mice
Kim, K., Kim, Y.-M., Park, M.-J., Park, K., Chang, H. K., Park, T. K., Chung, H.-H., & Kang, C. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4939 · Cited by 21
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Jones, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3463 · Cited by 771
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.023 · Cited by 628
Metadata
- Authors
- Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V.-A., & Gao, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-11-15
- Volume
- 110
- Issue
- 10
- Pages
- 1503-1513
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2095959011
- Cited by
- 270
- References
- 55
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.